As of 2025-09-17, the Intrinsic Value of Sana Biotechnology Inc (SANA) is -5.12 USD. This SANA valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.10 USD, the upside of Sana Biotechnology Inc is -265.10%.
Based on its market price of 3.10 USD and our intrinsic valuation, Sana Biotechnology Inc (SANA) is overvalued by 265.10%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.12 - -5.12 | -5.12 | -265.10% |
| P/E | (14.47) - (15.83) | (15.15) | -588.7% |
| DDM - Stable | (7.15) - (25.97) | (16.56) | -634.2% |
| DDM - Multi | (6.70) - (19.71) | (10.09) | -425.6% |
| Market Cap (mil) | 763.72 |
| Beta | 0.31 |
| Outstanding shares (mil) | 246.36 |
| Enterprise Value (mil) | 692.45 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.78% |
| Cost of Debt | 5.00% |
| WACC | 7.23% |